Kinase inhibitors for the treatment of inflammatory and autoimmune disorders

被引：39
|
作者：
Bhagwat, Shripad S. [1 ]
机构：
[1] Ambit Biosci, San Diego, CA 92121 USA
来源：
PURINERGIC SIGNALLING | 2009年 / 5卷 / 01期
关键词：
Kinase inhibitors; Anti-inflammatory agents; Autoimmune modulators; IKK2; inhibitors; Syk inhibitors; Lck inhibitors; JAK3; KAPPA-B KINASE; IKK-BETA INHIBITORS; POTENT; DISCOVERY; SYK; JAK3; LCK; SAR; DERIVATIVES; BMS-345541;
D O I：
10.1007/s11302-008-9117-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Drugs targeting inhibition of kinases for the treatment of inflammation and autoimmune disorders have become a major focus in the pharmaceutical and biotech industry. Multiple kinases from different pathways have been the targets of interest in this endeavor. This review describes some of the recent developments in the search for inhibitors of IKK2, Syk, Lck, and JAK3 kinases. It is anticipated that some of these compounds or newer inhibitors of these kinases will be approved for the treatment of rheumatoid arthritis, psoriasis, organ transplantation, and other autoimmune diseases.
引用
收藏
页码：107 / 115
页数：9
相关论文
共 50 条
  • [41] A novel series of matrix metalloproteinase inhibitors for the treatment of inflammatory disorders
    Baxter, AD
    Bird, J
    Bhogal, R
    Massil, T
    Minton, KJ
    Montana, J
    Owen, DA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (07) : 897 - 902
  • [42] Hematopoietic prostaglandin D synthase inhibitors for the treatment of inflammatory disorders
    Thurairatnam, Sukanthini
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [43] Janus kinase inhibitors in autoimmune diseases
    O'Shea, John J.
    Kontzias, Apostolos
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    Laurence, Arian
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 111 - 115
  • [44] ARE THE INFLAMMATORY BOWEL DISEASES AUTOIMMUNE DISORDERS
    SNOOK, J
    GUT, 1990, 31 (09) : 961 - 963
  • [45] Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review
    Long, Zhiyong
    Xiang, Wang
    Xiao, Wei
    Min, Yu
    Qu, Fei
    Zhang, Bolin
    Zeng, Liuting
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] Chronic inflammatory autoimmune disorders and atherosclerosis
    Abu-Raya, S.
    Abou-Raya, A.
    Naim, A.
    Abuelkheir, H.
    AUTOIMMUNITY, PT C: THE MOSAIC OF AUTOIMMUNITY, 2007, 1107 : 56 - 67
  • [47] Comparative immunogenomics of autoimmune and inflammatory disorders
    Becker, KG
    TISSUE ANTIGENS, 2004, 64 (04): : 343 - 343
  • [48] Dementia caused by inflammatory and autoimmune disorders
    Rahmani, M.
    Benabdeljlil, M.
    Alamouri, F.
    Aidi, S.
    Boutbibe, F.
    El Alaoui Faris, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 685 - 685
  • [49] Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders
    Robak, Tadeusz
    Robak, Ewa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (07) : 921 - 947
  • [50] Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases
    Leban, Johann
    Vitt, Daniel
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (01): : 66 - 72
12345